A combination antihypertensive tablet that merges Olmesartan medoxomil with Hydrochlorothiazide, enabling effective blood pressure control when monotherapy with an angiotensin receptor blocker is insufficient.Indications:Treatment of essential hypertension not well-controlled by Olmesartan alone.Main Active Ingredients:- Olmesartan medoxomil.- Hydrochlorothiazide.Precautions:- Contraindicated in patients with hypersensitivity to any component, severe hepatic or renal impairment, or anuria, and during the 2nd & 3rd trimesters of pregnancy.- Use caution and monitor blood pressure and kidney function in patients who are volume or salt-depleted, or have renal artery stenosis.- May precipitate electrolyte imbalances, monitor serum creatinine, potassium, sodium, and uric acid levels.Side Effects:- Dizziness, headache, fatigue, gastrointestinal symptoms (e.g., nausea, stomach discomfort), cough, urinary or respiratory tract infections, and musculoskeletal pain.- Elevated uric acid, potassium, glucose, liver enzymes, blood urea, creatinine; decreased sodium, chloride, magnesium; and altered platelet counts.Drug–Drug Interactions:- Other antihypertensives, NSAIDs, diuretics, antiarrhythmics, steroids, antidiabetics, anticoagulants (e.g., warfarin), cardiac glycosides (e.g., digoxin), and lipid-lowering agents.- Aliskiren in diabetic patients or those with renal impairment (GFR <60 mL/min/1.73 m²).

- Take orally as directed by a physician.- Swallow the tablet with sufficient water.- Do not stop suddenly; if a dose is missed, take the next one as scheduled (do not double up).- Store below 25 °C, protected from moisture, and out of reach of children.

• Anti-hypertensive
• Heart Health

Olmesartan medoxomil, Hydrochlorothiazide, Microcrystalline cellulose, Lactose monohydrate, Low-substituted hydroxypropyl cellulose, Hypromellose, Magnesium stearate, Titanium dioxide (E171), Talc, Iron oxide yellow (E172).